4,170 reports of this reaction
1.5% of all CORTISONE ACETATE reports
#20 most reported adverse reaction
MATERNAL EXPOSURE DURING PREGNANCY is the #20 most commonly reported adverse reaction for CORTISONE ACETATE, manufactured by Boiron. There are 4,170 FDA adverse event reports linking CORTISONE ACETATE to MATERNAL EXPOSURE DURING PREGNANCY. This represents approximately 1.5% of all 272,029 adverse event reports for this drug.
Patients taking CORTISONE ACETATE who experience maternal exposure during pregnancy should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MATERNAL EXPOSURE DURING PREGNANCY is a less commonly reported adverse event for CORTISONE ACETATE, but still significant enough to appear in the safety profile.
In addition to maternal exposure during pregnancy, the following adverse reactions have been reported for CORTISONE ACETATE:
The following drugs have also been linked to maternal exposure during pregnancy in FDA adverse event reports:
MATERNAL EXPOSURE DURING PREGNANCY has been reported as an adverse event in 4,170 FDA reports for CORTISONE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MATERNAL EXPOSURE DURING PREGNANCY accounts for approximately 1.5% of all adverse event reports for CORTISONE ACETATE, making it a notable side effect.
If you experience maternal exposure during pregnancy while taking CORTISONE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.